Jury says Gilead didn’t violate CDC patent on HIV drugs



Gilead Sciences did not violate the United States Centers for Disease and Prevention’s (CDC) patents on an HIV prevention regimen called pre-exposure prophylaxis (PeEP), a jury in Delaware conclud…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento